同和药业
(300636)
| 流通市值：37.57亿 | | | 总市值：43.63亿 |
| 流通股本：3.64亿 | | | 总股本：4.23亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 534,774,791.43 | 512,753,422.59 | 412,014,668.4 | 75,019,955 |
| 应收票据及应收账款 | 118,735,203.7 | 70,771,939.06 | 115,810,339.95 | 95,519,021.78 |
| 应收账款 | 118,735,203.7 | 70,771,939.06 | 115,810,339.95 | 95,519,021.78 |
| 应收款项融资 | 9,510,794.18 | 98,988 | 2,887,088 | 89,370 |
| 预付款项 | 14,112,742.22 | 14,157,517.46 | 7,438,834 | 3,577,825.32 |
| 其他应收款合计 | 4,408,841.41 | 2,894,961.98 | 1,864,620.48 | 1,371,411.34 |
| 存货 | 494,396,038.27 | 523,416,724.31 | 484,727,180.7 | 474,534,543.08 |
| 一年内到期的非流动资产 | 74,859,886.8 | 49,652,222.21 | - | - |
| 其他流动资产 | 3,976,183.79 | 23,237,934.9 | 23,916,240.98 | 14,712,349.59 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,284,774,481.8 | 1,196,983,710.51 | 1,078,658,972.51 | 664,824,476.11 |
| 非流动资产: | | | | |
| 其他债权投资 | 564,586,956.64 | 488,842,238.78 | - | - |
| 长期股权投资 | 3,300,000 | - | - | - |
| 固定资产 | 980,778,301.71 | 1,008,211,108.35 | 591,596,845.22 | 608,509,686.42 |
| 在建工程 | 532,046,761.69 | 503,080,855.77 | 896,301,070.72 | 863,964,920.44 |
| 使用权资产 | 2,617,343.16 | 2,829,560.16 | 3,041,777.16 | 3,253,994.16 |
| 无形资产 | 19,939,125.83 | 20,166,730.73 | 20,394,335.63 | 20,621,940.53 |
| 递延所得税资产 | 288,001.09 | 231,975.78 | 146,469.26 | 148,211.82 |
| 其他非流动资产 | 2,537,867.9 | 1,093,558.91 | 553,488,626.39 | 251,668,309.1 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,106,094,358.02 | 2,024,456,028.48 | 2,064,969,124.38 | 1,748,167,062.47 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,390,868,839.82 | 3,221,439,738.99 | 3,143,628,096.89 | 2,412,991,538.58 |
| 流动负债: | | | | |
| 短期借款 | 449,531,253.77 | 429,312,470.41 | 373,143,064.11 | 405,683,787.98 |
| 应付票据及应付账款 | 104,682,126.21 | 130,393,252.94 | 127,849,262.95 | 146,171,945.27 |
| 其中：应付票据 | 68,725,245.92 | 81,558,584.22 | 81,501,123.31 | 86,648,051.61 |
| 应付账款 | 35,956,880.29 | 48,834,668.72 | 46,348,139.64 | 59,523,893.66 |
| 合同负债 | 3,390,836.95 | 2,087,288.19 | 1,672,016.55 | 2,042,352.33 |
| 应付职工薪酬 | 15,654,913.25 | 19,110,493.32 | 17,599,125.83 | 16,937,251.92 |
| 应交税费 | 1,450,607.21 | 1,668,327.16 | 2,252,080.36 | 1,273,382.48 |
| 其他应付款合计 | 29,039,752.12 | 31,530,191.23 | 45,457,809.75 | 45,264,630.8 |
| 一年内到期的非流动负债 | 68,392,781.42 | 87,609,124.92 | 71,059,462.72 | 71,059,462.72 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 672,142,270.93 | 701,711,148.17 | 639,032,822.27 | 688,432,813.5 |
| 非流动负债: | | | | |
| 长期借款 | 399,000,000 | 250,000,000 | 266,833,318.7 | 305,833,318.7 |
| 租赁负债 | 1,810,035.01 | 2,037,867.88 | 2,255,577.25 | 2,473,286.62 |
| 递延收益 | 3,978,484.88 | 4,018,461.14 | 3,908,437.4 | 3,948,413.66 |
| 递延所得税负债 | 42,490,987.36 | 37,223,137.53 | 40,617,244.42 | 34,942,085.03 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 447,279,507.25 | 293,279,466.55 | 313,614,577.77 | 347,197,104.01 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,119,421,778.18 | 994,990,614.72 | 952,647,400.04 | 1,035,629,917.51 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 423,136,145 | 423,136,145 | 423,136,145 | 350,264,883 |
| 资本公积 | 1,271,952,653.88 | 1,270,749,298.05 | 1,279,008,789.92 | 560,313,361.29 |
| 减:库存股 | 24,944,490.6 | 25,176,321 | 41,574,151 | 42,004,201 |
| 盈余公积 | 61,712,424.6 | 61,712,424.6 | 51,127,608.79 | 51,127,608.79 |
| 未分配利润 | 539,590,328.76 | 496,027,577.62 | 479,282,304.14 | 457,659,968.99 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,271,447,061.64 | 2,226,449,124.27 | 2,190,980,696.85 | 1,377,361,621.07 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,271,447,061.64 | 2,226,449,124.27 | 2,190,980,696.85 | 1,377,361,621.07 |
| 负债和股东权益合计 | 3,390,868,839.82 | 3,221,439,738.99 | 3,143,628,096.89 | 2,412,991,538.58 |
| 公告日期 | 2024-04-25 | 2024-04-25 | 2023-10-26 | 2023-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |